PL2167095T3 - Związki fenotiazynowe do leczenia łagodnych zaburzeń poznawczych - Google Patents
Związki fenotiazynowe do leczenia łagodnych zaburzeń poznawczychInfo
- Publication number
- PL2167095T3 PL2167095T3 PL08762390T PL08762390T PL2167095T3 PL 2167095 T3 PL2167095 T3 PL 2167095T3 PL 08762390 T PL08762390 T PL 08762390T PL 08762390 T PL08762390 T PL 08762390T PL 2167095 T3 PL2167095 T3 PL 2167095T3
- Authority
- PL
- Poland
- Prior art keywords
- cognitive impairment
- mild cognitive
- treating mild
- phenothiazine compounds
- phenothiazine
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title 1
- 208000027061 mild cognitive impairment Diseases 0.000 title 1
- 125000001484 phenothiazinyl group Chemical class C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94500607P | 2007-06-19 | 2007-06-19 | |
| PCT/GB2008/002066 WO2008155533A2 (en) | 2007-06-19 | 2008-06-17 | Phenothiazine compounds for treating mild cognitive impairment |
| EP08762390.6A EP2167095B1 (en) | 2007-06-19 | 2008-06-17 | Phenothiazine compounds for treating mild cognitive impairment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2167095T3 true PL2167095T3 (pl) | 2019-11-29 |
Family
ID=39943003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08762390T PL2167095T3 (pl) | 2007-06-19 | 2008-06-17 | Związki fenotiazynowe do leczenia łagodnych zaburzeń poznawczych |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9211294B2 (enExample) |
| EP (1) | EP2167095B1 (enExample) |
| JP (1) | JP5725605B2 (enExample) |
| CN (1) | CN101820884B (enExample) |
| AU (1) | AU2008265045B2 (enExample) |
| BR (1) | BRPI0813670A2 (enExample) |
| CA (1) | CA2690746C (enExample) |
| DK (1) | DK2167095T3 (enExample) |
| ES (1) | ES2739546T3 (enExample) |
| HR (1) | HRP20191513T1 (enExample) |
| HU (1) | HUE045460T2 (enExample) |
| MY (1) | MY177001A (enExample) |
| PL (1) | PL2167095T3 (enExample) |
| PT (1) | PT2167095T (enExample) |
| SI (1) | SI2167095T1 (enExample) |
| WO (1) | WO2008155533A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602007008550D1 (de) | 2006-03-29 | 2010-09-30 | Wista Lab Ltd | 3,7-diamino-10h-phenothiazinsalze und ihre verwendung |
| SI2954932T1 (sl) * | 2007-10-03 | 2019-01-31 | Wista Laboratories Ltd. | Terapevtska uporaba diaminofenotiazinov |
| SG185094A1 (en) | 2010-04-30 | 2012-12-28 | Prostetta Antiviral Inc | Antiviral compounds |
| SI2673266T1 (sl) * | 2011-02-11 | 2016-11-30 | Wista Laboratories Ltd. | Fenotiazin diaminijeve soli in njihova uporaba |
| WO2012145567A1 (en) | 2011-04-20 | 2012-10-26 | Prosetta Antiviral Inc. | Antiviral compounds |
| EP3686181B1 (en) * | 2013-01-30 | 2024-07-17 | Ecolab USA Inc. | Hydrogen sulfide scavengers |
| US10304006B2 (en) * | 2013-02-15 | 2019-05-28 | The Charles Stark Draper Laboratory, Inc. | Method for integrating and fusing heterogeneous data types to perform predictive analysis |
| AU2016220096B2 (en) | 2015-02-17 | 2020-01-30 | Arizona Board Of Regents On Behalf Of Arizona State University | Phenothiazine analogues as mitochondrial therapeutic agents |
| SI4335517T1 (sl) * | 2016-07-25 | 2025-11-28 | Taurx Therapeutics Management Ltd. | Dajanje in odmerek diaminofenotiazinov |
| GB201614834D0 (en) * | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
| EP4385512B1 (en) * | 2018-07-26 | 2025-12-03 | TauRx Therapeutics Management Ltd. | Optimised dosage of diaminophenothiazines in populations |
| MY209608A (en) * | 2019-04-10 | 2025-07-24 | Genting Taurx Diagnostic Centre Sdn Bhd | Adaptive neurological testing method |
| GB201909454D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Enhancers |
| GB201909493D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Therapeutic interactions |
| GB201909506D0 (en) | 2019-07-02 | 2019-08-14 | Wista Lab Ltd | Synaptopathies |
| CA3257856A1 (en) | 2022-05-31 | 2023-12-07 | Wista Laboratories Ltd. | TREATMENT OF NEURODEGENERATIVE DISORDERS USING COMPOUNDS CONTAINING METHYLTHIONINIUM (MT) |
| KR20250154422A (ko) | 2023-03-03 | 2025-10-28 | 타우알엑스 쎄라퓨틱스 매니지먼트 리미티드 | 미세혈관 뇌질환 치료를 위한 디아미노페노티아진 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| GB0017060D0 (en) * | 2000-07-11 | 2000-08-30 | Hunter Fleming Ltd | Production, stabilisation and use of reduced forms of pharmaceutical compounds |
| GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| EP1617844A4 (en) * | 2003-04-03 | 2009-07-22 | Prana Biotechnology Ltd | TREATMENT OF NEUROLOGICAL DISEASES |
| WO2006032879A2 (en) * | 2004-09-23 | 2006-03-30 | Wista Laboratories Ltd. | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| CN101084204B (zh) * | 2004-09-23 | 2012-12-05 | 卫思道制药有限公司 | 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法 |
| WO2006091728A2 (en) * | 2005-02-24 | 2006-08-31 | The Trustees Of The University Of Pennsylvania | Microtubule stabilizing compounds and methods of their use |
| EP2001556B1 (en) * | 2006-03-29 | 2014-10-01 | Wista Laboratories Ltd. | Thioninium compounds and their use |
| DE602007008550D1 (de) | 2006-03-29 | 2010-09-30 | Wista Lab Ltd | 3,7-diamino-10h-phenothiazinsalze und ihre verwendung |
| WO2007110629A1 (en) | 2006-03-29 | 2007-10-04 | Wista Laboratories Ltd | Inhibitors of protein aggregation |
| SI2457905T1 (sl) | 2006-07-11 | 2016-12-30 | Wista Laboratories Ltd. | Postopki sinteze in/ali čiščenja diaminofenotiazinijevih spojin |
-
2008
- 2008-06-17 DK DK08762390.6T patent/DK2167095T3/da active
- 2008-06-17 BR BRPI0813670-0A2A patent/BRPI0813670A2/pt not_active Application Discontinuation
- 2008-06-17 US US12/665,608 patent/US9211294B2/en active Active
- 2008-06-17 ES ES08762390T patent/ES2739546T3/es active Active
- 2008-06-17 JP JP2010512761A patent/JP5725605B2/ja active Active
- 2008-06-17 HU HUE08762390A patent/HUE045460T2/hu unknown
- 2008-06-17 PT PT08762390T patent/PT2167095T/pt unknown
- 2008-06-17 WO PCT/GB2008/002066 patent/WO2008155533A2/en not_active Ceased
- 2008-06-17 PL PL08762390T patent/PL2167095T3/pl unknown
- 2008-06-17 CN CN2008801031955A patent/CN101820884B/zh active Active
- 2008-06-17 SI SI200832080T patent/SI2167095T1/sl unknown
- 2008-06-17 AU AU2008265045A patent/AU2008265045B2/en active Active
- 2008-06-17 CA CA2690746A patent/CA2690746C/en active Active
- 2008-06-17 MY MYPI20095255A patent/MY177001A/en unknown
- 2008-06-17 EP EP08762390.6A patent/EP2167095B1/en active Active
- 2008-06-17 HR HRP20191513 patent/HRP20191513T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008265045B2 (en) | 2014-02-27 |
| BRPI0813670A2 (pt) | 2014-12-30 |
| JP5725605B2 (ja) | 2015-05-27 |
| HUE045460T2 (hu) | 2019-12-30 |
| HRP20191513T1 (hr) | 2019-11-29 |
| US20100184752A1 (en) | 2010-07-22 |
| ES2739546T3 (es) | 2020-01-31 |
| CN101820884B (zh) | 2013-08-28 |
| EP2167095B1 (en) | 2019-05-29 |
| AU2008265045A1 (en) | 2008-12-24 |
| DK2167095T3 (da) | 2019-07-29 |
| CA2690746C (en) | 2018-01-02 |
| SI2167095T1 (sl) | 2019-09-30 |
| US9211294B2 (en) | 2015-12-15 |
| MY177001A (en) | 2020-09-01 |
| CA2690746A1 (en) | 2008-12-24 |
| WO2008155533A3 (en) | 2009-02-19 |
| PT2167095T (pt) | 2019-08-06 |
| WO2008155533A2 (en) | 2008-12-24 |
| CN101820884A (zh) | 2010-09-01 |
| JP2010530403A (ja) | 2010-09-09 |
| EP2167095A2 (en) | 2010-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2167095T (pt) | Compostos de fenotiazina para o tratamento de comprometimento cognitivo leve | |
| EP2504011A4 (en) | METHOD FOR TREATING EASY COGNITIVE IMPAIRMENT | |
| IL257418A (en) | Methods for treating addiction | |
| IL209895A0 (en) | Compounds for treating beta-amyloidoses | |
| GB2445465B (en) | Process for waste treatment | |
| IL198851A0 (en) | Methods for treating hypercholesterolemia | |
| EP2079414A4 (en) | SYSTEM FOR CHEMOHYPER THERMAL TREATMENT | |
| EP1877055A4 (en) | 4-AMINOQUINOLINE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASE CONDITIONS | |
| PT3028716T (pt) | Inibição do complemento para regeneração nervosa melhorada | |
| ZA200809528B (en) | Treatment for depressive disorders | |
| SI2001892T1 (sl) | Spojine imidazolotiazol za zdravljenje proliferacijskih bolezni | |
| AU2007288337A8 (en) | Compounds for treating proliferative disorders | |
| IL193410A0 (en) | Purification method for effluent | |
| ZA200809527B (en) | Treatment for depressive disorders | |
| IL213398A0 (en) | Compounds for treating cancer | |
| IL204728A0 (en) | Methods and compounds for treating retinol-related diseases | |
| IL198856A0 (en) | Compounds useful for treating neurodegenerative disorders | |
| GB0810364D0 (en) | Improved effluent treatment | |
| PT2481407T (pt) | Compostos para utilização no tratamento de distúrbios cognitivos | |
| ZA201002993B (en) | Novel compounds for fabric treatment | |
| IL209947A (en) | Compounds for the treatment of corneal inflammation | |
| GB0707556D0 (en) | Treatment for cancer | |
| ZA200901672B (en) | Compounds for treating proliferative disorders | |
| IL205752A0 (en) | Octahydroquinolizines for antidiabetic treatment | |
| ZA200903242B (en) | Treatment for multiple myeloma |